| Product NDC: | 25021-132 |
| Proprietary Name: | Levofloxacin |
| Non Proprietary Name: | Levofloxacin |
| Active Ingredient(s): | 5 mg/mL & nbsp; Levofloxacin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-132 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090343 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110620 |
| Package NDC: | 25021-132-83 |
| Package Description: | 24 POUCH in 1 CARTON (25021-132-83) > 1 BAG in 1 POUCH > 150 mL in 1 BAG |
| NDC Code | 25021-132-83 |
| Proprietary Name | Levofloxacin |
| Package Description | 24 POUCH in 1 CARTON (25021-132-83) > 1 BAG in 1 POUCH > 150 mL in 1 BAG |
| Product NDC | 25021-132 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levofloxacin |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110620 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | LEVOFLOXACIN |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |